CENTURY ENT INT received resumption guidance
CENTURY ENT INT received the resumption guidance from the Stock Exchange on August 1 and 7, 2025, which includes: addressing the issue of not expressing an opinion and disclosing sufficient information for investors to assess the financial condition; proving compliance with Listing Rule 13.24; re-compliance with Rules 3.05, 3.10(1), 3.21, and 13.92; and informing the market of all material information for shareholders and investors to assess the company's condition
According to the Zhitong Finance APP, CENTURY ENT INT (00959) announced that on August 1, 2025, and August 7, 2025, the company received two letters from the Stock Exchange, which included the following guidelines regarding the resumption of trading of the company's shares: (i) address the issues that led to the disclaimer of opinion, explain why a disclaimer of opinion is no longer necessary, and disclose sufficient information in accordance with Listing Rule 13.50A to allow investors to make an informed assessment of its financial condition; (ii) demonstrate compliance with Listing Rule 13.24; (iii) re-comply with Listing Rule 3.05; (iv) re-comply with Listing Rules 3.10(1), 3.21, and 13.92; and (v) inform the market of all material information so that the company's shareholders and other investors can assess the company's condition
